Multidose use of palivizumab vials may provide considerable savings

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.550, 2008-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Palivizumab

By Scott L.J. Lamb H.M.

Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. : 305-311

Adis International

Access to resources Recommend Favorite

NHS efficiency savings may be unsustainable

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 664, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Palivizumab: A Review of its Use as Prophylaxis for Serious Respiratory Syncytial Virus Infection

By Fenton Caroline Scott Lesley J. Plosker Greg L.

Pediatric Drugs, Vol. 6, Iss. 3, 2004-01 ,pp. : 177-197

Adis International

Access to resources Recommend Favorite

Injectable anticoagulants may offer significant savings

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 560, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

"Considerable controversy exists about the use of race and ethnicity in scientific and medical research"

Inpharma, Vol. 1, Iss. 1398, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite